Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies

doi:10.4252/wjsc.v11.i11.920

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8080)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

444

WORD

222

HTML

3949

Figures (1-3)

277

Tables (1-6)

144

Sum=5036

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

483

Download

795

Sum=1278

Publishing Process of This Article

Item

Count

Browse

741

Download

1025

Sum=1766

Nov 26, 2019 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Nov 26, 2019; 11(11): 920-936
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.920

Full Size Figure Download Figure

Figure 3 Survival analysis for CD133/CD44/CD166 expression profiles in colorectal cancer. The association of CD133/CD44/CD166 transcript expression with cancer survival in the COADREAD Cancer Genome Atlas dataset was analyzed using the SurvExpress portal[62]. Kaplan-Meier plot and Cox survival statistics were established with maximized risk group assessment (466 patients with 255 in low vs 211 in high risk profile). The log rank for equal curves indicated a significant difference (P value = 0.0007) with a hazard ratio of 2.12 (95%CI: 1.35-3.31, P value = 0.0009).

Citation: Vincent A, Ouelkdite-Oumouchal A, Souidi M, Leclerc J, Neve B, Van Seuningen I. Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies. World J Stem Cells 2019; 11(11): 920-936
URL: https://www.wjgnet.com/1948-0210/full/v11/i11/920.htm
DOI: https://dx.doi.org/10.4252/wjsc.v11.i11.920